Speakers
TTS Speakers Confirmed to date
- Richard Rodriguez, Director, Office of Technology Transfer, NIH, USA
- Fred Reinhart, Vice President Finance, AUTM (Association of University Technology Managers) USA
- Jonathan Hepple, Bioscience Managers Limited, UK
- Tony Sedgwick, CEO, Novacta, UK
- Karl Keegan, Managing Director, Head of Research (UK), Global Sector Head of Life Sciences Research, Cannacord Adams
- Werner Wolf, Venture Partner, TVM Capital, Germany
- Mathias Uhlen, Royal Institute of Technology (KTH), Sweden
- Brian Clark, Vice President, European Federation of Biotechnology, Denmark
- Prabudda Ganguli, CEO, Vision IPR, Innovation Advisor to the Government of India
- Peter Ruile, Chief Operating Officer, Ascenion, Germany
- Nick Rodgers, CEO, IPSO Ventures, UK
- Richard Seabrook, Head of Business Development, Wellcome Trust, UK
- Beat Mollet, Intellectual Property Coordinator, Nestlé Research Centre, Switzerland
- Diane Romza Kutz, Partner, Chair of Life Sciences, Neil Gerber Eisenberg LLP, USA
- Ann Lane, Tech Transfer Office, University College London, UK
- Cathy Prescott, Director, Biolatris Ltd., UK
- Angelika Bonin-Debs, Global Licensing, Boehringer Ingelheim GmbH, Germany
- Patrik Frei, CEO, Venture Valuations AG, Switzerland
- Joe Dupere, Director, Healthcare Investment Banking, Deutsche Bank, UK
- Boo Edgar, GIBBS Director, CEO, CIP Professional Services, Sweden
- Mike May, Director, Business Development, IPBO, Belgium
- Joni Catalano-Sherman, Corporate Director, Technology Transfer & Academic Relations, Johnson&Johnson
- Ruth Keir, Executive Director, Worldwide Business Development, Pfizer
